Minireviews
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1903-1917
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1903
Table 3 Comparison of median overall survival between the upfront surgery group and the neoadjuvant therapy plus surgery group
Ref.
Country
NCT number/Name
Variable
Upfront surgery
NAT plus surgery
P value
Golcher et al[7]GermanyNCT00335543mOS; mo14.417.40.96
Versteijne et al[8]NetherlandsPREOPANCmOS; mo14.615.60.83
Casadei et al[9]Italy-mOS; mo19.522.40.97
Reni et al[10]ItalyPACT-15mOS; mo20.4,26.438.2NM
Satoi et al[11]JapanPrep-02/JSAP-05mOS; mo26.636.70.015